NEW YORK , July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023 and June 24, 2025.

image for news Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT

HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Investment Partners, Inc. (NYSE: VRTS), which operates a multi-boutique asset management business, today announced that it will release its financial results for the second quarter of 2025 before the market opens on Friday, July 25, 2025. George R. Aylward, president and chief executive officer, and Michael A. Angerthal, executive vice president and chief financial officer, will host a conference call and webcast with the investment community at 10:00 a.

image for news Virtus Investment Partners to Announce Second Quarter 2025 Results on Friday, July 25

Retail, Consumer Firms Seize Business Benefits of Analytics — Neutral

III   Business Wire — July 11, 2025

STAMFORD, Conn.--(BUSINESS WIRE)---- $III #AI--Retail and consumer packaged goods companies are transforming operations and gaining new business tools using AI and advanced analytics, ISG says.

image for news Retail, Consumer Firms Seize Business Benefits of Analytics

Luminar to Provide Quarterly Business Update on August 12, 2025 — Neutral

LAZR   Business Wire — July 11, 2025

ORLANDO, Fla.--(BUSINESS WIRE)--Luminar (Nasdaq: LAZR), a leading global automotive technology company, today announced it will provide its business update for the second quarter of 2025 following the close of the market on Tuesday, August 12, 2025. On August 12, 2025 at 4:00 p.m. EDT (1:00 p.m. PDT), the company will publish materials detailing its second quarter financials and broader business update, which will be available on its Investor Relations website at https://investors.luminartech.c.

image for news Luminar to Provide Quarterly Business Update on August 12, 2025

VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across, defi, traditional finance and emerging sectors. A former executive on Bay Street and res.

image for news BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor

New Era Helium JV nears closing of land deal for 250MW AI data center in Texas — Positive

NEHC   Proactive Investors — July 11, 2025

New Era Helium Inc (NASDAQ:NEHC) announced that due diligence has been completed and satisfied on a 235-acre site in Ector County, Texas, where its joint venture, Texas Critical Data Centers (TCDC), plans to build a 250-megawatt AI and high-performance computing data center campus. The land transaction is expected to close on or before the end of the month.

image for news New Era Helium JV nears closing of land deal for 250MW AI data center in Texas

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Olo Inc. (NYSE: OLO), its board of directors, its executive officers, and founder and current CEO Noah H. Glass for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of Olo to Thoma Bravo Discover Fund IV, L.P.

image for news OLO BREAKING INVESTIGATION: BFA Law is Investigating Olo Inc.'s Board for Breaching its Fiduciary Duties in Connection with the $10.25 Merger Price - Contact BFA Law

Airline Stocks Cheer Delta's Upbeat Report — Positive

AAL  DAL  JBLU  LUV  UAL   Schaeffers Research — July 10, 2025

Delta Air Lines Inc (NYSE:DAL) stock is up 12.4% to trade at $56.99 today, after the airliner's top-line beat for the second quarter.

image for news Airline Stocks Cheer Delta's Upbeat Report

Alphabet: Technical Momentum Is Starting to Turn — Positive

GOOG  GOOGL   MarketBeat — July 10, 2025

While the broader market, led by the technology sector and many of the Magnificent Seven members, continues to hit new highs, GOOGL has remained one of the few laggards.

image for news Alphabet: Technical Momentum Is Starting to Turn

Delta is studying changes to its premium-cabin offerings, similar to what airlines have done in coach.

image for news Business class+? Delta says segmentation is coming to high-end cabins

SGOV & TLT: A Tale Of Two ETFs And The Duration Trade — Positive

TLT   Seeking Alpha — July 10, 2025

The highly anticipated 'duration trade' in long bonds like TLT has underperformed despite the Fed lowering rates by 100bp since their peak. TLT's price hasn't rebounded as expected because its yield hasn't shifted enough, even though short-term rates have declined. In fact, YoY, long rates have risen! I've consistently favored the short end of the curve, particularly the SGOV ETF, which has provided reliable returns during this period. I continue to endorse it moving forward.

image for news SGOV & TLT: A Tale Of Two ETFs And The Duration Trade

MONSEY, N.Y., July 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of WK Kellogg Co. (NYSE: KLG) (“Kellogg”) to Ferrero Group for $23.00 per share in cash.

image for news KLG Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of WK Kellogg Co. to Ferrero Group

Aspen: Navigating Profit In A Hardening Insurance Market — Positive

AHL   Seeking Alpha — July 10, 2025

Aspen has demonstrated strong underwriting profitability and value creation despite industry headwinds, supported by a hardening insurance market and disciplined capital allocation. The company's integrated 'One Aspen' approach and ACM platform differentiate it, enabling bespoke risk solutions and stable, growing fee income from third-party capital. Aspen continues to generate economic profit with solid free cash flow and an attractive valuation, with the market pricing in conservative growth assumptions.

image for news Aspen: Navigating Profit In A Hardening Insurance Market

Otis Worldwide Q2 Preview: Anticipating Weak Equipment Sales — Negative

OTIS   Seeking Alpha — July 10, 2025

I reiterate a Sell rating on Otis Worldwide Corporation, with a fair value of $82 per share, due to a persistently weak growth outlook. Otis faces ongoing headwinds from sluggish China real estate and global housing markets, resulting in declining new equipment sales. Management's optimism on China's recovery appears premature, especially amid continued property price declines and U.S.-China tariff uncertainties.

image for news Otis Worldwide Q2 Preview: Anticipating Weak Equipment Sales

Aurora Innovation CEO on Self-Driving Trucks, Working With Nvidia — Neutral

AUR  NVDA   Bloomberg Markets and Finance — July 10, 2025

Aurora Innovation CEO Chris Urmson discusses the company's autonomous trucking service, the regulatory environment and partnership with Nvidia. He speaks with Ed Ludlow at the Sun Valley conference.

image for news Aurora Innovation CEO on Self-Driving Trucks, Working With Nvidia

Apple, Visa and Mastercard Antitrust Lawsuit Tossed by Federal Judge — Positive

AAPL  MA  V   PYMNTS — July 10, 2025

Apple, Visa and Mastercard reportedly won a legal victory in an antitrust lawsuit. The tech giant and the two payment firms convinced a federal judge to dismiss the lawsuit accusing them of colluding to stifle competition, Reuters reported Thursday (July 10).

image for news Apple, Visa and Mastercard Antitrust Lawsuit Tossed by Federal Judge

Rhythm Pharmaceuticals, Inc.'s IMCIVREE and new oral MC4R agonist, bivamelagon, show strong efficacy in rare obesity disorders, especially hypothalamic obesity (HO). HO represents a blockbuster market opportunity with minimal competition, as MC4R agonists address the root cause, unlike GLP-1s. Pipeline expansion, including oral and weekly MC4R agonists, positions Rhythm for long-term market dominance in rare obesity beyond 2040.

image for news Rhythm: Oral Bivamelagon Data Signals Dominance In Hypothalamic Obesity Market

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Centene, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/centene-corporation-class-action-lawsuit.

image for news CNC BREAKING CLASS ACTION: Centene Corporation has been Sued for Securities Fraud; Investors with Losses are Notified to Contact BFA Law by September 8 Court Deadline (NYSE:CNC)

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of DallasNews Corporation (NASDAQ: DALN) to Hearst for $14.00 in cash per share is fair to DallasNews shareholders. Halper Sadeh encourages DallasNews shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether DallasNews and.

image for news DALN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DallasNews Corporation Is Fair to Shareholders

Baker Hughes CEO Lorenzo Simonelli on oil volatility — Positive

BKR  BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   CNBC Television — July 10, 2025

Baker Hughes CEO Lorenzo Simonelli on Thursday said that despite short-term oil volatility, he still sees "long-term positive trends" for the industry.

image for news Baker Hughes CEO Lorenzo Simonelli on oil volatility